Cognitive function during 3 years of growth hormone in previously GH-treated young adults with PWS.
Demi J Trueba-TimmermansLionne N GrootjenAlicia F JuriaansEva F MahabierGerthe F KerkhofEdmond H H M RingsAnita C S Hokken-KoelegaPublished in: European journal of endocrinology (2023)
Three years of GH-treatment in young adults with PWS with 33% of the pediatric dose, maintains total, verbal and performance IQ. The emotional and behavioral disturbances remained stable and were similar compared to peers with other intellectual disabilities.